The use of combined oral contraceptive pills (COCP) and metformin, either as monotherapy or combined, was evaluated for the treatment of polycystic ovary syndrome (PCOS) in a recent systematic review published in the journal Clinical Endocrinology. Study authors systematically searched electronic databases for applicable randomized controlled trials that assessed these therapies for the management of…

Agile Therapeutics has resubmitted to the Food and Drug Administration (FDA) the New Drug Application (NDA) for its product, Twirla, an investigational low-dose combined hormonal contraceptive patch (AG200-15). Based on the results from a comparative wear study, the resubmitted NDA will address the FDA’s questions on in vivo adhesion, additional information on the Company’s manufacturing…